Published in Expert Opin Ther Pat on November 08, 2012
Structural basis of AMPK regulation by small molecule activators. Nat Commun (2013) 1.58
Targeting the AMP-Activated Protein Kinase for Cancer Prevention and Therapy. Front Oncol (2013) 1.08
AMPK: An emerging target for modification of injury-induced pain plasticity. Neurosci Lett (2013) 0.91
Activation of AMP-activated protein kinase revealed by hydrogen/deuterium exchange mass spectrometry. Structure (2013) 0.91
Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers. Oncotarget (2016) 0.86
AMPK activators: mechanisms of action and physiological activities. Exp Mol Med (2016) 0.82
Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding. Nat Commun (2016) 0.76
Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain. Curr Drug Targets (2016) 0.76
Architectural plasticity of AMPK revealed by electron microscopy and X-ray crystallography. Sci Rep (2016) 0.75
Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators. ChemMedChem (2015) 0.75
Identification of Direct Activator of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by Structure-Based Virtual Screening and Molecular Docking Approach. Int J Mol Sci (2017) 0.75
Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5). Bioorg Med Chem Lett (2006) 0.88
A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5). Bioorg Med Chem Lett (2006) 0.82